BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Johnson & Johnson Reports Q4 and Full-Year 2024 Results

  January 23, 2025

   · 

  19 min read
• Press Releases

  Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore

  January 23, 2025

   · 

  6 min read
• Press Releases

  Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America

  January 23, 2025

   · 

  9 min read
• 

  Press Releases

  Andersen Disease Market Size to Reach USD 2.1 Billion by 2035, Impelled by Advancements in Gene Therapies

  In the year 2024, 7 key markets of the andersen disease market amounted to USD 1.2 Billion. IMARC Group forecast that the same is expected to reach USD 2.1 Billion for 7MM by 2035, by exhibiting a CAGR of 5.71% during the forecast period, which is 2025-2035

  January 23, 2025

   · 

  9 min read
• 

  Press Releases

  Androgen Insensitivity Syndrome Market Size to Reach USD 674.8 Million by 2035, Impelled Advances in Genetic Testing and Diagnostics

  The androgen insensitivity syndrome market size reached a value of USD 396.1 Million in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 674.8 Million by 2035, exhibiting a growth rate (CAGR) of 4.98% during 2025-2035.

  January 23, 2025

   · 

  6 min read